Hypothesis

Telomere length serves as a readout of chromatin informational entropy rather than a simple division counter. When nucleosome positioning and histone modification patterns become disordered, the entropy of the chromatin state rises, exposing telomeric repeats to aberrant processing and accelerating attrition. This predicts that cells with high chromatin entropy will exhibit short telomeres even if they have undergone few divisions, and that lowering chromatin entropy (e.g., by enhancing histone deacetylase activity) will slow telomere shortening independent of telomerase.

Mechanistic rationale

• Telomeric DNA is embedded in heterochromatin marked by H3K9me3 and HP1 binding. Loss of these marks increases local DNA accessibility.
• Increased accessibility raises the probability of oxidative damage and aberrant recombination at telomeres, effectively raising the informational entropy of the telomere‑adjacent chromatin domain.
• Entropy can be approximated from single‑cell ATAC‑seq or Hi‑C contact variance; higher variance correlates with lower nucleosome occupancy.
• Thus telomere shortening reflects two processes: (1) loss of repeats due to the end‑replication problem, and (2) repeat loss driven by entropy‑dependent damage.

Testable predictions

1. Correlation across single cells – In a population of non‑dividing neurons, cells with higher chromatin entropy (measured by scATAC‑seq fragment‑size dispersion) will have significantly shorter telomeres (measured by telomere‑specific FISH or qPCR) than low‑entropy peers, despite similar division histories (estimated via mitochondrial DNA mutation load).
2. Intervention – Pharmacological increase of SIRT6 activity (which promotes H3K9 deacetylation and heterochromatin formation) in human fibroblasts will reduce chromatin entropy metrics and attenuate telomere shortening over 30 days, even when telomerase activity is inhibited.
3. Directionality – Inducing telomere damage (e.g., via TRF2 dominant‑negative expression) will raise local chromatin entropy, detectable as increased nucleosome‑free‑region variability at subtelomeric regions, establishing a feedback loop.

Experimental design (outline)

• Collect peripheral blood mononuclear cells from young and old donors; perform simultaneous scATAC‑seq, scRNA‑seq, and telomere length assay (Telomere‑seq). Compute per‑cell entropy from ATAC‑seq fragment length distribution and nucleosome‑score.
• Use linear mixed models to test entropy predicting telomere length after controlling for age and proliferation marker Ki‑67.
• In vitro, treat IMR‑90 fibroblasts with SIRT6 activator (MDL‑801) or vehicle; assess chromatin entropy by MNase‑seq variance and telomere length by qPCR at days 0, 10, 20, 30. Include a telomerase inhibitor (BIBR1532) arm to isolate entropy effects.
• For causality, generate a doxycycline‑inducible TRF2‑DN construct in HEK293 cells; induce for 48 h, then measure subtelomeric ATAC‑seq entropy and telomere‑associated γH2AX foci.

Potential outcomes and falsification

• Support: Significant negative correlation between chromatin entropy and telomere length in non‑dividing cells; entropy reduction by SIRT6 activation slows telomere attrition despite telomerase blockade.
• Falsification: No correlation observed, or entropy manipulation fails to alter telomere shortening rates, indicating telomere length remains primarily a replication counter.

By linking telomere dynamics to chromatin information theory, this hypothesis reframes aging as a thermodynamic drift of nuclear organization, offering a concrete, falsifiable framework that extends beyond the end‑replication model.